Shenzhen YHLO Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Shenzhen YHLO Biotech has a total shareholder equity of CN¥2.6B and total debt of CN¥717.7M, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are CN¥4.0B and CN¥1.5B respectively. Shenzhen YHLO Biotech's EBIT is CN¥265.6M making its interest coverage ratio -2.3. It has cash and short-term investments of CN¥780.5M.
Key information
28.1%
Debt to equity ratio
CN¥717.73m
Debt
| Interest coverage ratio | -2.3x |
| Cash | CN¥780.48m |
| Equity | CN¥2.55b |
| Total liabilities | CN¥1.49b |
| Total assets | CN¥4.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688575's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥965.8M).
Long Term Liabilities: 688575's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥522.3M).
Debt to Equity History and Analysis
Debt Level: 688575 has more cash than its total debt.
Reducing Debt: 688575's debt to equity ratio has reduced from 54.1% to 28.1% over the past 5 years.
Debt Coverage: 688575's debt is well covered by operating cash flow (85.4%).
Interest Coverage: 688575 earns more interest than it pays, so coverage of interest payments is not a concern.